Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Diabetic Macular Edema and Retinal Vein Occlusion

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04085341
Recruitment Status : Recruiting
First Posted : September 11, 2019
Last Update Posted : September 25, 2019
Sponsor:
Information provided by (Responsible Party):
Graybug Vision

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 2020
Estimated Study Completion Date : April 2020